By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2408 Timberloch Place, Suite B-4

The Woodlands  Texas  77380-1012  U.S.A.
Phone: 281-367-5892 Fax: 281-363-8796




Company News
Zonagen (ZONA) Effects Name Change To Repros Therapeutics Inc. (RPRX) 5/3/2006 2:42:24 PM
Zonagen (ZONA) Reports First Quarter 2006 Financial Results 5/1/2006 1:03:23 PM
Zonagen (ZONA) Reports Fourth Quarter And Year End 2005 Financial Results 3/13/2006 1:24:26 PM
Zonagen (ZONA) Announces 2006 Annual Meeting Of Stockholders 2/8/2006 1:26:27 PM
Zonagen (ZONA) Announces Positive Top-Line Results Of Androxal(TM) Study 2/3/2006 11:13:36 AM
Zonagen (ZONA) Receives IRB Approval to Commence Phase III Study Of Androxal(TM) For The Treatment Of Testosterone Deficiency 1/9/2006 4:27:19 PM
Zonagen (ZONA) Announces U.S. IND For The Study Of Proellex(TM) In The Treatment Of Uterine Fibroids Has Become Effective 12/16/2005 1:12:00 PM
Zonagen (ZONA) Reports Third Quarter 2005 Financial Results And Provides Update On Proellex And Androxal Clinical Development Programs 11/11/2005 1:43:51 PM
Zonagen (ZONA) Reports Fourth Quarter And Year End 2004 Financial Results And Provides An Update On Company's Core Programs10/19/2005 5:13:10 PM
Zonagen (ZONA) Receives Notification Of Issuance Of U.S. Patent On Progenta10/19/2005 5:13:03 PM